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Abstract
The establishment of methods for directive differentiation from human embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs) is important for regenerative medicine. Although Sry-related HMG box 17 (SOX17)
overexpression in ESCs leads to differentiation of either extraembryonic or definitive endoderm cells, respectively, the
mechanism of these distinct results remains unknown. Therefore, we utilized a transient adenovirus vector-mediated
overexpression system to mimic the SOX17 expression pattern of embryogenesis. The number of alpha-fetoprotein-positive
extraembryonic endoderm (ExEn) cells was increased by transient SOX17 transduction in human ESC- and iPSC-derived
primitive endoderm cells. In contrast, the number of hematopoietically expressed homeobox (HEX)-positive definitive
endoderm (DE) cells, which correspond to the anterior DE in vivo, was increased by transient adenovirus vector-mediated
SOX17 expression in human ESC- and iPSC-derived mesendoderm cells. Moreover, hepatocyte-like cells were efficiently
generated by sequential transduction of SOX17 and HEX. Our findings show that a stage-specific transduction of SOX17 in
the primitive endoderm or mesendoderm promotes directive ExEn or DE differentiation by SOX17 transduction,
respectively.
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Introduction
There are two distinct endoderm lineages in early embryogen-
esis, the extraembryonic endoderm (ExEn) and the definitive
endoderm (DE). The first of these lineages, the ExEn plays crucial
roles in mammalian development, although it does not contribute
to the formation of body cells. In early embryogenesis, a part of the
inner cell mass of the blastocyst differentiates into the primitive
endoderm (PrE). The PrE differentiates into the ExEn that
composes the parietal endoderm, which contributes to the primary
yolk sac, and the visceral endoderm, which overlies the epiblast
[1,2]. In contrast, the second of the endoderm lineages, the DE
arises from the primitive streak (PS), which is called the
mesendoderm [3]. The DE has the ability to differentiate into
the hepatic and pancreatic tissue [4].
The establishment of human embryonic stem cells (ESCs) [5]
and human induced pluripotent stem cells (iPSCs) [6,7] has
opened up new opportunities for basic research and regenerative
medicine. To exploit the potential of human ESCs and iPSCs, it is
necessary to understand the mechanisms of their differentiation.
Although growth factor-mediated ExEn or DE differentiation is
widely performed, it leads to a heterogeneous population
[8,9,10,11]. Several studies have utilized not only growth factors
but also modulation of transcription factors to control downstream
signaling cascades [10,12,13]. Sox17, an Sry-related HMG box
transcription factor, is required for development of both the ExEn
and DE. In mice, during ExEn and DE development, Sox17
expression is first observed in the PrE and in the anterior PS,
respectively [14]. Previous study showed that stable Sox17
overexpression promotes ExEn differentiation from mouse ESCs
[12]. On the other hand, another previous study has demonstrated
that DE progenitors can be established from human ESCs by
stable expression of SOX17 [10]. The mechanism of these
discrepancies which occurs in SOX17 transduction still remains
unknown. Also, the role of SOX17 in human ExEn differentiation
still remains unknown. Therefore, it is quite difficult to promote
directive differentiation into either ExEn or DE cells by SOX17
transduction.
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21780In this study, we utilized SOX17 as a stage-specific regulator of
ExEn and DE differentiation from human ESCs and iPSCs. The
human ESC- and iPSC-derived cells were transduced with
SOX17-expressing adenovirus vector (Ad-SOX17), and the
resulting phenotypes were assessed for their ability to differentiate
into ExEn and DE cells in vitro. In addition, we examined whether
SOX17-transduced cells have the ability to differentiate into the
hepatic lineage. The results showed that stage-specific overexpres-
sion of the SOX17 transcription factor promotes directive
differentiation into either ExEn or DE cells.
Results
The induction of human ESC-derived PrE cells and
human ESC-derived mesendoderm cells
To determine the appropriate stage for SOX17 transduction,
ExEn or DE cells were differentiated from human ESCs by a
conventional method using BMP4 (20 ng/ml) or Activin A
(100 ng/ml), respectively (Figures S1 and S2). Experiments for
bidirectional differentiation using BMP4 and Activin A indicated
that PrE cells were obtained on day 1 (Figure S1)and mesendoderm
cells were obtained on day 3 (Figure S2). We expected that
stage-specific SOX17 transduction into PrE cells or mesendoderm
cells could promote ExEn or DE differentiation, because the time
period of intiation of SOX17 expression was correlated with the
time period of formation of PrE cells (day 1) (Figure S1C) and
mesendoderm cells (day 3) (Figure S2C), respectively.
PrE stage-specific SOX17 overexpression promotes
directive ExEn differentiation from human ESCs
To examine the effect of forced and transient expression of
SOX17 on the differentiation of human ESC- and iPSC-derived
cells, we used a fiber-modified adenovirus (Ad) vector containing
the EF-1a promoter and a stretch of lysine residues (KKKKKKK,
K7) peptides in the C-terminal region of the fiber knob. The K7
peptide targets heparan sulfates on the cellular surface, and the
fiber-modified Ad vector containing the K7 peptides has been
shown to be efficient for transduction into many kinds of cells
[15,16].
Because the time period of initiation of SOX17 expression was
correlated with the time period of formation of PrE cells (day 1)
(Figure S1), we expected that stage-specific SOX17 transduction
Figure 1. Efficient ExEn differentiation from human ESC- and iPSC-derived PrE cells by SOX17 transduction. (A–D) Undifferentiated
human ESCs (H9) and BMP4-induced human ESC-derived cells, which were cultured with the medium containing BMP4 (20 ng/ml) for 0, 1, 2, 3, and 4
days, were transduced with 3,000 VP/cell of Ad-SOX17 for 1.5 h. Ad-SOX17-transduced cells were cultured with 20 ng/ml of BMP4, and then the gene
expression levels of (A) the ExEn markers (AFP, GATA4, LAMB1, and SOX7), (B) the trophectoderm markers (CDX2, GATA2, hCGa, and hCGb), (C) the
pluripotent marker (NANOG), and (D) the DE marker (GSC) were examined by real-time RT-PCR on day 5 of differentiation. The horizontal axis
represents the day on which the cells were transduced with Ad-SOX17. The expression levels of undifferentiated human ESCs on day 0 were defined
1.0. (E) On day 1, human ESC-derived PrE cells, which were cultured with the medium containing BMP4 for 1 day, were transduced with Ad-LacZ or
Ad-SOX17 and cultured until day 5. The ExEn cells were subjected to immunostaining with anti-AFP or anti-SOX7 antibodies, and then analyzed by
flow cytometry. (F) After Ad-LacZ or Ad-SOX17 transduction, the efficacies of ExEn differentiation from the human ES cell line (H9) and the three
human iPS cell lines (201B7, Dotcom, and Tic) were compared on day 5 of differentiation. All data are represented as the means6SD (n=3).
doi:10.1371/journal.pone.0021780.g001
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examined the stage-specific role of SOX17 in ExEn differentia-
tion. Ad-SOX17 transduction was performed in human ESCs
treated with BMP4 for 0, 1, 2, 3, or 4 days, and the Ad-SOX17-
transduced cells were cultured with medium containing BMP4
until day 5 (Figures 1A–1D). We confirmed the expression of
exogenous SOX17 in the human ESC-derived mesendoderm cells
transduced with Ad-SOX17 (Figure S3). Since BMP4 is known for
its capability to induce both ExEn and trophectoderm [8,9], we
analyzed not only the expression levels of ExEn markers but also
those of trophectoderm markers by real-time RT-PCR after 5 days
of differentiation (Figures 1A and 1B). The transduction of Ad-
SOX17 on day 1 led to the highest expression levels of ExEn
markers, alpha-fetoprotein (AFP), GATA4, laminin B1 (LAMB1),
and SOX7 [17,18,19]. In contrast, the expression levels of the
trophectoderm markers CDX2, GATA2, hCGa (human chorionic
gonadotropin), and hCGb [20] were down-regulated in Ad-
SOX17-transduced cells as compared with non-transduced cells
(Figure 1B). The expression levels of the pluripotent marker
NANOG and DE marker GSC were not increased by SOX17
transduction (Figures 1C and 1D). We confirmed that there were
no differences between non-transduced cells and Ad-LacZ-
transduced cells in gene expression levels of all the markers
investigated in Figures 1A–1D (data not shown). Therefore, we
concluded that ExEn cells were efficiently induced from Ad-
SOX17-transduced PrE cells.
The effects of SOX17 transduction on the ExEn differentiation
from human ESC-derived PrE cells were also assessed by
quantifying AFP- or SOX7-positive ExEn cells. The percentage
of AFP- or SOX7-positive cells was significantly increased in Ad-
SOX17-transduced cells (69.7% and 63.3%, respectively)
(Figure 1E). Similar results were observed in the human iPS cell
lines (201B7, Dotcom, and Tic) (Figure 1F). These findings
indicated that stage-specific SOX17 overexpression in human
ESC-derived PrE cells enhances ExEn differentiation.
Mesendoderm stage-specific SOX17 overexpression
promotes directive DE differentiation from human ESCs
To examine the effects of transient SOX17 overexpression on
DE differentiation from human ESCs, we optimized the timing
of the Ad-SOX17 transduction. Ad-SOX17 transduction was
performed in human ESCs treated with Activin A (100 ng/ml)
f o r0 ,1 ,2 ,3 ,o r4d a y s ,a n dt h eA d - S O X 1 7 - t r a n s d u c e dc e l l s
were cultured with medium containing Activin A (100 ng/ml)
until day 5 (Figures 2A–2C). Using a fiber-modified Ad vector,
both undifferentiated human ESCs and Activin A-induced
human ESC-derived cells were efficiently transduced (Figure
S4). The transduction of SOX17 on day 3 led to the highest
expression levels of the DE markers FOXA2 [21], GSC [22],
GATA4 [17], and HEX [23] (Figure 2A). In contrast to the DE
markers, the expression levels of the pluripotent marker
NANOG [24] were down-regulated in Ad-SOX17-transduced
cells as compared with non-transduced cells (Figure 2B). The
expression levels of the ExEn marker SOX7 [14] were up-
regulated, when Ad-SOX17 transduction was performed into
human ESCs treated with Activin A (100 ng/ml) for 0, 1, or 2
days (Figure 2C). On the other hand, the expression levels of the
ExEn marker SOX7 were significantly down-regulated, when
Ad-SOX17 transduction was performed into human ESCs
treated with Activin A (100 ng/ml) for 3 or 4 days, indicating
that SOX17 overexpression prior to mesendoderm formation
(day 0, 1, and 2) promoted not only DE differentiation but also
ExEn differentiation. Similar results were obtained with the
human iPS cell line (Tic) (Figure S5). Although the expression
levels of the mesoderm marker FLK1 [25] did not exhibit any
change when Ad-SOX17 transduction was performed into
human ESCs treated with Activin A (100 ng/ml) for 0, 1, or 2
days (Figure 2D), their expression levels were significantly down-
regulated when Ad-SOX17 transduction was performed into
human ESCs treated with Activin A (100 ng/ml) for 3 or 4 days.
These results suggest that SOX17 overexpression promotes
directive differentiation from mesendoderm cells into the DE
cells, but not into mesoderm cells. We also confirmed that Ad-
vector mediated gene expression in the human ESC-derived
mesendoderm cells (day 3) continued until day 6 and
disappeared on day 10 (Figure S6). SOX17 transduction in
the human ESC-derived cells on day 3 and 4 had no effect on
cell viability, while that in the cells on day 0, 1, and 2 resulted in
severely impaired cell viability (Figure S7), probably because
SOX17 transduction directedt h ec e l l so nd a y0 ,1 ,a n d2t o
differentiate into ExEn cells but the medium containing Activin
A (100 ng/ml) was inappropriate for ExEn cells. We confirmed
that there were no differences between non-transduced cells and
Ad-LacZ-transduced cells in gene expression levels of all the
markers investigated in Figures 2A–2D (data not shown). These
results indicated that stage-specific SOX17 overexpression in
human ESC-derived mesendoderm cells is essential for promot-
ing efficient DE differentiation.
It has been previously reported that human ESC-derived
mesendoderm cells and DE cells became CXCR4-positive
(.80%) by culturing human ESCs with Activin A (100 ng/ml)
[26]. However, Activin A is not sufficient for homogenous
differentiation of c-Kit/CXCR4-double-positive DE cells [10,11]
or HEX-positive anterior DE cells [23]. Seguin et al. and
Morrison et al. reported that the differentiation efficiency of c-
Kit/CXCR4-double-positive DE cells was approximately 30% in
the absence of stable Sox17 expression and that of HEX-positive
anterior DE cells was only about 10% [10,23]. Therefore, we
next examined whether Ad-SOX17 transduction improves the
differentiation efficiency of c-Kit/CXCR4-double-positive DE
cells and HEX-positive anterior DE cells. Human ESC-derived
mesendoderm cells were transduced with Ad-SOX17, and the
number of CXCR4/c-Kit-double-positive cells was analyzed by
using a flow cytometer. The percentage of CXCR4/c-Kit-
double-positive cells was significantly increased in Ad-SOX17-
transduced cells (67.7%), while that in Ad-LacZ-transduced cells
was only 22% (Figure 2E). The percentage of HEX-positive cells
was also significantly increased in Ad-SOX17-transduced cells
(53.7%), while that in Ad-LacZ-transduced cells was approxi-
mately 11% (Figure 2F). Similar results were also observed in the
three human iPS cell lines (201B7, Dotcom, and Tic) (Figure 2G).
These findings indicated that stage-specific SOX17 overexpres-
sion in human ESC-derived mesendoderm cells promotes
efficient differentiation of DE cells.
Ad-SOX17-transduced cells tend to differentiate into the
hepatic lineage
To investigate whether Ad-SOX17-transduced cells have the
ability to differentiate into hepatoblasts and hepatocyte-like cells,
Ad-SOX17-transduced cells were differentiated according to our
previously described method [13]. Our previous report demon-
strated that transient HEX transduction efficiently generates
hepatoblasts from human ESC- and iPSC-derived DE cells. The
hepatic differentiation protocol used in this study is illustrated in
Figure 3A. After the hepatic differentiation, the morphology of
human ESCs transduced with Ad-SOX17 followed by Ad-HEX
was gradually changed into a hepatocyte morphology: polygonal
in shape with distinct round nuclei by day 18 (Figure 3B). We also
Directive ExEn or DE Differentiation by SOX17
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differentiation. For this purpose, we used a human ES cell line
(H9) and three human iPS cell lines (201B7, Dotcom, Tic). On day
18 of differentiation, the gene and protein expression analysis
showed up-regulation of the hepatic markers albumin (ALB) [27],
cytochrome P450 2D6 (CYP2D6), CYP3A4, and CYP7A1 [28]
mRNA and ALB, CYP2D6, CYP3A4, CYP7A1, and cytokeratin
(CK)18 proteins in both Ad-SOX17- and Ad-HEX-transduced
cells transduced cells as compared with both Ad-LacZ- and Ad-
HEX-transduced cells (Figures 4A and 4B). These results indicated
that Ad-SOX17-transduced cells were more committed to the
hepatic lineage than non-transduced cells.
Discussion
The directed differentiation from human ESCs and iPSCs is a
useful model system for studying mammalian development as well as
a powerful tool for regenerative medicine [29]. In the present study,
we elucidated the bidirectional role of SOX17 on either ExEn or DE
differentiation from human ESCs and iPSCs. We initially confirmed
that initiation of SOX17 expression was consistent with the time
period of PrE or mesendoderm cells formation (Figures S1 and S2).
We speculated that stage-specific transient SOX17 transduction in
PrE or mesendoderm could enhance ExEn or DE differentiation
from human ESCs and iPSCs, respectively.
Figure 2. Efficient DE differentiation from human ESC- and iPSC-derived mesendoderm cells by SOX17 transduction. (A–D)
Undifferentiated human ESCs (H9) and Activin A-induced human ESC-derived cells, which were cultured with the medium containing Activin A
(100 ng/ml) for 0, 1, 2, 3, and 4 days, were transduced with 3,000 VP/cell of Ad-SOX17 for 1.5 h. Ad-SOX17-transduced cells were cultured with
100 ng/ml of Activin A, and the gene expression levels of (A) the DE markers (FOXA2, GSC, and GATA4) and anterior DE marker (HEX), (B) the
pluripotent marker (NANOG), (C) the ExEn marker (SOX7), and (D) the mesoderm marker (FLK1) were examined by real-time RT-PCR on day 5 of
differentiation. The horizontal axis represents the day on which the cells were transduced with Ad-SOX17. The expression levels of human ESCs on
day 0 were defined 1.0. (E, F) After human ESCs were cultured with 100 ng/ml of Activin A for 3 days, human ESC-derived mesendoderm cells were
transduced with Ad-LacZ or Ad-SOX17 and cultured until day 5. Ad-LacZ- or Ad-SOX17-transduced DE cells were subjected to immunostaining with
anti-c-Kit, anti-CXCR4 (E) and anti-HEX antibodies (F) and then analyzed by flow cytometry. (G) After Ad-LacZ or Ad-SOX17 transduction, the DE
differentiation efficacies of the human ES cell line (H9) and three human iPS cell lines (201B7, Dotcom, and Tic) were compared at day 5 of
differentiation. All data are represented as the means6SD (n=3).
doi:10.1371/journal.pone.0021780.g002
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differentiation giving heterogeneous populations containing both
ExEn and DE cells were obtained (Figures 2A–2C). Qu et al.
reported that SOX17 promotes random differentiation of mouse
ESCs into PrE cells and DE cells in vitro [30], which is in consistent
with the present study. Previously, Niakan et al. and Seguin et al.
respectively demonstrated that ESCs could promote either ExEn
or DE differentiation by stable SOX17 expression, respectively
[10,12]. Although these discrepancies might be attributable to
differences in the species used in the experiments (i.e., human
versus mice), SOX17 might have distinct functions according to
the appropriate differentiation stage. To elucidate these discrep-
ancies, we examined the stage-specific roles of SOX17 in the
present study, and found that human ESCs and iPSCs could
differentiate into either ExEn or DE cells when SOX17 was
overexpressed at the PrE or mesendoderm stage, respectively, but
not when it was overexpressed at the pluripotent stage (Figures 1
and 2). This is because endogenous SOX17 is strongly expressed
in the PrE and primitive streak tissues but only slightly expressed
in the inner cell mass, our system might adequately reflect the
early embryogenesis [14,31].
In ExEn differentiation from human ESCs, stage-specific
SOX17 overexpression in human ESC-derived PrE cells promot-
ed efficient ExEn differentiation and repressed trophectoderm
differentiation (Figures 1A and 1B), although SOX17 transduction
at the pluripotent stage did not induce the efficient differentiation
of ExEn cells. In our protocol, the stage-specific overexpression of
SOX17 could elevate the efficacy of AFP-positive or SOX7-
positive ExEn differentiation from human ESCs and iPSCs. The
reason for the efficient ExEn differentiation by SOX17 transduc-
tion might be due to the fact that SOX17 lies downstream from
GATA6 and directly regulates the expression of GATA4 and
GATA6 [12]. Although it was previously been reported that
Sox17 plays a substantial role in late-stage differentiation of ExEn
cells in vitro [32], those reports utilized embryoid body formation,
in which other types of cells, including endoderm, mesoderm, and
ectoderm cells, might have influences on cellular differentiation.
The present study showed the role of SOX17 in a homogeneous
differentiation system by utilizing a mono-layer culture system.
In DE differentiation from human ESCs, we found that DE cells
were efficiently differentiated from the human ESC-derived
mesendoderm cells by stage-specific SOX17 overexpression
(Figure 2). Therefore, we concluded that SOX17 plays a
significant role in the differentiation of mesendoderm cells to DE
cells. Although SOX17 overexpression before the formation of
mesendoderm cells did not affect mesoderm differentiation,
SOX17 transduction at the mesendoderm stage selectively
promoted DE differentiation and repressed mesoderm differenti-
ation (Figures 2A and 2D). These results show that SOX17 plays a
crucial role in decision of DE differentiation from mesendoderm
cells, as previous studies suggested [33,34]. Interestingly, SOX17
transduction at the pluripotent stage promoted not only DE
Figure 3. Hepatic Differentiation of Human ESC- and iPSC-Derived DE Cells Transduced with Ad-HEX. (A) The procedure for
differentiation of human ESCs and iPSCs into hepatoblasts and hepatocyte-like cells is presented schematically. Both hESF-GRO and hESF-DIF medium
were supplemented with 5 factors and 0.5 mg/ml fatty acid-free BSA, as described in the Materials and Methods section. (B) Sequential
morphological changes (day 0–18) of human ESCs (H9) differentiated into hepatocyte-like cells via the DE cells and the hepatoblasts are shown. The
scale bar represents 50 mm.
doi:10.1371/journal.pone.0021780.g003
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of Activin A (Figures 2A and 2C), demonstrating that transduction
at an inappropriate stage of differentiation prevents directed
differentiation. These results suggest that stage-specific SOX17
transduction mimicking the gene expression pattern in embryo-
genesis could selectively promote DE differentiation.
Another important finding about DE differentiation is that the
protocol in the present study was sufficient for nearly homoge-
neous DE and anterior DE differentiation by mesendoderm stage-
specific SOX17 overexpression; the differentiation efficacies of c-
Kit/CXCR4-double-positive DE cells and HEX-positive anterior
DE cells were approximately 70% and 54%, respectively
(Figures 2E and 2F). The conventional differentiation protocols
without gene transfer were not sufficient for homogenous DE and
anterior DE differentiation; the differentiation efficacies of DE and
anterior DE were approximately 30% and 10%, respectively
[10,11,23]. One of the reasons for the efficient DE differentiation
by SOX17 transduction might be the activation of the FOXA2
gene which could regulate many endoderm-associated genes [35].
Moreover, SOX17-transduced cells were more committed to the
hepatic lineage (Figure 4). This might be because the number of
HEX-positive anterior DE cell populations was increased by
SOX17 transduction. Recent studies have shown that the
conditional expression of Sox17 in the pancreas at E12.5, when
it is not normally expressed, is sufficient to promote biliary
differentiation at the expense of endocrine cells [36]. Therefore,
we reconfirmed that our protocol in which SOX17 was transiently
transduced at the appropriate stage of differentiation was useful for
DE and hepatic differentiation from human ESCs and iPSCs.
Using human iPSCs as well as human ESCs, we confirmed that
stage-specific overexpression of SOX17 could promote directive
differentiation of either ExEn or DE cells (Figures 1F, 2G, and
4A). Interestingly, a difference of DE and hepatic differentiation
efficacy among human iPS cell lines was observed (Figures 1F and
2G). Therefore, it would be necessary to select a human iPS cell
line that is suitable for hepatic differentiation in the case of medical
applications, such as liver transplantation.
To control cellular differentiation mimicking embryogenesis, we
employed Ad vectors, which are one of the most efficient transient
gene delivery vehicles and have been widely used in both
experimental studies and clinical trials [37]. Recently, we have
also demonstrated that ectopic HEX expression by Ad vectors in
human ESC-derived DE cells markedly enhances the hepatic
differentiation [13]. Thus, Ad vector-mediated transient gene
Figure 4. Characterization of hepatocyte-like cells from human ESC- and iPSC-derived DE cells. (A) The Ad-LacZ-transduced cells and Ad-
SOX17-transduced cells were transduced with 3,000 VP/cell of Ad-HEX for 1.5 h on day 6. On day 18 of differentiation, the levels of expression of the
hepatocyte markers (ALB, CYP2D6, CYP3A4, and CYP7A1) were examined by real-time RT-PCR in human ESC (H9)-derived hepatocyte-like cells and
human iPSC (201B7, Dotcom, or Tic)-derived hepatocyte-like cells. The gene expression profiles of cells transduced with both Ad-SOX17 and Ad-HEX
(black bar) were compared with those of cells transduced with both Ad-LacZ and Ad-HEX (gray bar). The expression level of primary human
hepatocytes (PH, hatched bar), which were cultured 48 h after plating the cells, were defined as 1.0. All data are represented as the means6SD (n=3).
(B) The expression of the hepatocyte markers ALB (green), CYP2D6 (red), CYP3A4 (red), CYP7A1 (red), and CK18 (green) was also examined by
immunohistochemistry on day 18 of differentiation. Nuclei were counterstained with DAPI (blue). The scale bar represents 50 mm.
doi:10.1371/journal.pone.0021780.g004
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differentiation.
In summary, the findings presented here demonstrate a stage-
specific role of SOX17 in the ExEn and DE differentiation from
human ESCs and iPSCs (Figure S8). Although previous reports
showed that SOX17 overexpression in ESCs leads to differenti-
ation of either ExEn or DE cells, we established a novel method to
promote directive differentiation by SOX17 transduction. Because
we utilized a stage-specific overexpression system, our findings
provide further evidence that the lineage commitment in this
method seems to reflects what is observed in embryonic
development. In the present study, both human ESCs and iPSCs
(3 lines) were used and all cell lines showed efficient ExEn or DE
differentiation, indicating that our novel protocol is a powerful tool
for efficient and cell line-independent endoderm differentiation.
Moreover, the establishing methods for efficient hepatic differen-
tiation by sequential SOX17 and HEX transduction would be
useful for in vitro applications such as screening of pharmacological
compounds as well as for regenerative therapy.
Materials and Methods
In vitro Differentiation
Before the initiation of cellular differentiation, the medium of
human ESCs and iPSCs was exchanged for a defined serum-free
medium hESF9 [38] and cultured as we previously reported.
hESF9 consists of hESF-GRO medium (Cell Science & Technol-
ogy Institute) supplemented with 5 factors (10 mg/ml human
recombinant insulin, 5 mg/ml human apotransferrin, 10 mM2 -
mercaptoethanol, 10 mM ethanolamine, and 10 mM sodium
selenite), oleic acid conjugated with fatty acid free bovine albumin,
10 ng/ml FGF2, and 100 ng/ml heparin (all from Sigma).
To induce, ExEn cells, human ESCs and iPSCs were cultured
for 5 days on a gelatin-coated plate in mouse embryonic
conditioned-medium supplemented with 20 ng/ml BMP4 (R&D
system) and 1% FCS (GIBCO-BRL).
The differentiation protocol for induction of DE cells,
hepatoblasts, and hepatocyte-like cells was based on our previous
report with some modifications [13]. Briefly, in DE differentiation,
human ESCs and iPSCs were cultured for 5 days on a Matrigel
(BD)-coated plate in hESF-DIF medium (Cell Science &
Technology Institute) supplemented with the above-described 5
factors, 0.5 mg/ml BSA, and 100 ng/ml Activin A (R&D
Systems). For induction of hepatoblasts, the DE cells were
transduced with 3,000 VP/cell of Ad-HEX for 1.5 h and cultured
in hESF-DIF (Cell Science & Technology Institute) medium
supplemented with the above-described 5 factors, 0.5 mg/ml BSA,
10 ng/ml bone morphology protein 4 (BMP4) (R&D Systems),
and 10 ng/ml FGF4 (R&D systems). In hepatic differentiation, the
cells were cultured in hepatocyte culture medium (HCM)
supplemented with SingleQuots (Lonza), 10 ng/ml hepatocyte
growth factor (HGF) (R&D Systems), 10 ng/ml Oncostatin M
(OsM) (R&D Systems), and 10
27 M dexamethasone (DEX)
(Sigma).
Human ESC and iPSC Culture
A human ES cell line, H9 (WiCell Research Institute), was
maintained on a feeder layer of mitomycin C-treated mouse
embryonic fibroblasts (Millipore) with Repro Stem (Repro CELL),
supplemented with 5 ng/ml fibroblast growth factor 2 (FGF2)
(Sigma). Human ESCs were dissociated with 0.1 mg/ml dispase
(Roche Diagnostics) into small clumps, and subcultured every 4 or
5 days. Two human iPS cell lines generated from the human
embryonic lung fibroblast cell line MCR5 were provided from the
JCRB Cell Bank (Tic, JCRB Number: JCRB1331; and Dotcom,
JCRB Number: JCRB1327) [39,40]. These human iPS cell lines
were maintained on a feeder layer of mitomycin C-treated mouse
embryonic fibroblasts with iPSellon (Cardio), supplemented with
10 ng /ml FGF2. Another human iPS cell line, 201B7, generated
from human dermal fibroblasts (HDF) was kindly provided by Dr.
S. Yamanaka (Kyoto University) [6]. The human iPS cell line
201B7 was maintained on a feeder layer of mitomycin C-treated
mouse embryonic fibroblasts with Repro Stem (Repro CELL),
supplemented with 5 ng/ml FGF2 (Sigma). Human iPSCs were
dissociated with 0.1 mg/ml dispase (Roche Diagnostics) into small
clumps, and subcultured every 5 or 6 days.
Adenovirus (Ad) Vectors
Ad vectors were constructed by an improved in vitro ligation
method [41,42]. The human SOX17 gene (accession number
NM_022454) was amplified by PCR using primers designed to
incorporate the 59 BamHI and 39 XbaI restriction enzyme sites:
Fwd 59-gcagggatccagcgccatgagcagcccgg-39 and Rev 59-cttctaga-
gatcagggacctgtcacacgtc-39. The human SOX17 gene was inserted
into pcDNA3 (Invitrogen), resulting in pcDNA-SOX17, and then
the human SOX17 gene was inserted into pHMEF5 [15], which
contains the human EF-1a promoter, resulting in pHMEF-
SOX17. The pHMEF-SOX17 was digested with I-CeuI/PI-SceI
and ligated into I-CeuI/PI-SceI-digested pAdHM41-K7 [16],
resulting in pAd-SOX17. The human elongation factor-1a (EF-
1a) promoter-driven LacZ- or HEX-expressing Ad vectors, Ad-
LacZ or Ad-HEX, were constructed previously. [13,43]. Ad-
SOX17, Ad-HEX, and Ad-LacZ, which contain a stretch of lysine
residue (K7) peptides in the C-terminal region of the fiber knob for
more efficient transduction of human ESCs, iPSCs, and DE cells,
were generated and purified as described previously [13,15,43].
The vector particle (VP) titer was determined by using a
spectrophotometric method [44].
Flow Cytometry
Single-cell suspensions of human ESCs, iPSCs, and their
derivatives were fixed with methanol at 4uC for 20 min, then
incubated with the primary antibody, followed by the secondary
antibody. Flow cytometry analysis was performed using a FACS
LSR Fortessa flow cytometer (Becton Dickinson).
RNA Isolation and Reverse Transcription-Polymerase
Chain Reaction (RT-PCR)
Total RNA was isolated from human ESCs, iPSCs, and their
derivatives using ISOGENE (Nippon Gene) according to the
manufacture’s instructions. Primary human hepatocytes were
purchased from CellzDirect. cDNA was synthesized using
500 ng of total RNA with a Superscript VILO cDNA synthesis
kit (Invitrogen). Real-time RT-PCR was performed with Taqman
gene expression assays (Applied Biosystems) or SYBR Premix Ex
Taq (TaKaRa) using an ABI PRISM 7000 Sequence Detector
(Applied Biosystems). Relative quantification was performed
against a standard curve and the values were normalized against
the input determined for the housekeeping gene, glyceraldehyde 3-
phosphate dehydrogenase (GAPDH). The primer sequences used
in this study are described in Table S1.
Immunohistochemistry
The cells were fixed with methanol or 4% PFA. After blocking
with PBS containing 2% BSA and 0.2% Triton X-100 (Sigma), the
cells were incubated with primary antibody at 4uC for 16 h,
followed by incubation with a secondary antibody that was labeled
Directive ExEn or DE Differentiation by SOX17
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temperature for 1 h. All the antibodies are listed in Table S2.
Crystal Violet Staining
The human ESC-derived cells that had adhered to the wells
were stained with 200 ml of 0.3% crystal violet solution at room
temperature for 15 min. Excess crystal violet was then removed
and the wells were washed three times. Fixed crystal violet was
solubilized in 200 ml of 100% ethanol at room temperature for
15 min. Cell viability was estimated by measuring the absorbance
at 595 nm of each well using a microtiter plate reader (Sunrise,
Tecan).
LacZ Assay
The human ESC- and iPSC-derived cells were transduced with
Ad-LacZ at 3,000 VP/cell for 1.5 h. After culturing for the
indicated number of days, 5-bromo-4-chloro-3-indolyl b-D-
galactopyranoside (X-Gal) staining was performed as described
previously [15].
Supporting Information
Table S1 List of Taqman probes and primers used in
this study.
(DOC)
Table S2 List of antibodies used in this study.
(DOC)
Figure S1 PrE cells formation from human ESCs on day
1 of differentiation. (A) The procedure for differentiation of
human ESCs and iPSCs to ExEn cells by treatment with BMP4
(20 ng/ml) is presented schematically. (B) Human ESCs (H9) were
morphologically changed during ExEn differentiation; when
human ESCs were cultured with the medium containing BMP4
(20 ng/ml) for 5 days, the cells began to show flattened epithelial
morphology. The scale bar represents 50 mm. (C–E) The
tTemporal protein expression analysis during ExEn differentiation
was performed by immunohistochemistry. The PrE markers
COUP-TF1 [21] (red), SOX17 [14] (red), and SOX7 [14] (red)
were detected on day 1. In contrast to the PS markers, the
expression of the DE marker GSC [22] (red) was not detected and
the level of the pluripotent marker NANOG (green) declined
between day 0 and day 1. Nuclei were counterstained with DAPI
(blue). The scale bar represents 50 mm.
(PDF)
Figure S2 Mesendoderm cells formation from human
ESCs on day 3 of differentiation. (A) The procedure for
differentiation of human ESCs and iPSCs to DE cells by treatment
with Activin A (100 ng/ml) is presented schematically. hESF-GRO
medium was supplemented with 5 factors and 0.5 mg/ml fatty acid
free BSA, as described in the Materials and Methods. (B) Human
ESCs (H9) were morphologically changed during DE differentia-
tion; when human ESCs were cultured with the medium containing
Activin A (100 ng/ml) for 5 days, the morphology of the cells began
to show visible cell-cell boundaries. The scale bar represents 50 mm.
(C–E) The tTemporal protein expression analysis during DE
differentiation was performed by immunohistochemistry. The
anterior PS markers FOXA2 [21] (red), GSC [22] (red), and
SOX17 [14] (red) were adequately detected on day 3. The PS
marker T [45] (red) was detected until day 3. In contrast to the PS
markers, the expression of the pluripotent marker NANOG [24]
(green) declined between day 2 and day 3. Nuclei were
counterstained with DAPI (blue). The scale bar represents 50 mm.
(PDF)
Figure S3 Overexpression of SOX17 mRNA in human
ESC (H9)-derived PS cells by Ad-SOX17 transduction.
Human ESC-derived PS cells (day 1) were transduced with
3,000VP/cell of Ad-SOX17 for 1.5 h. On day 3 of differentiation,
real-time RT-PCR analysis of the SOX17 expression was
performed in Ad-LacZ-transduced cells and Ad-SOX17-trans-
duced cells. On the y axis, the expression levels of undifferentiated
human ESCs on day 0 was were taken defined as 1.0. All data are
represented as the means6SD (n=3).
(PDF)
Figure S4 Efficient transduction in Activin A-induced
human ESC (H9)-derived cells by using a fiber-modified
Ad vector containing the EF-1a promoter. Undifferentiated
human ESCs and Activin A-induced human ESC-derived cells,
which were cultured with the medium containing Activin A
(100 ng/ml) for 0, 1, 2, 3, and 4 days, were transduced with 3,000
vector particles (VP)/cell of Ad-LacZ for 1.5 h. The day after
transduction, X-gal staining was performed. The scale bar
represents 100 mm. Similar results were obtained in two
independent experiments.
(PDF)
Figure S5 Optimization of the time period for Ad-
SOX17 transduction to promote DE differentiation from
human iPSCs (Tic). Undifferentiated human iPSCs and Activin
A-induced human iPSC-derived cells, which were cultured with
the medium containing Activin A (100 ng/ml) for 0, 1, 2, 3, and 4
days, were transduced with 3,000 VP/cell of Ad-SOX17 for 1.5 h.
Ad-SOX17-transduced cells were cultured with Activin A
(100 ng/ml) until day 5, and then real-time RT-PCR analysis
was performed. The horizontal axis represents the day on which
the cells were transduced with Ad-SOX17. On the y axis, the
expression levels of undifferentiated cells on day 0 was were taken
defined as 1.0. All data are represented as the means6SD (n=3).
(PDF)
Figure S6 Time course of LacZ expression in human
ESC (H9)-derived mesendoderm cells transduced with
Ad-LacZ. The hHuman ESC-derived mesendoderm cells (day 3)
were transduced with 3,000 VP/cell of Ad-LacZ for 1.5 h. On
days 4, 5, 6, 8, and 10, X-gal staining was performed. Note that
human ESC-derived cells were passaged on day 5. The scale bar
represents 100 mm. Similar results were obtained in two
independent experiments.
(PDF)
Figure S7 Optimization of the time period for Ad-
SOX17 transduction into Activin A-induced human ESC
(H9)-derived cells. Undifferentiated human ESCs and Activin
A-induced hESC-derived cells, which were cultured with the
medium containing Activin A (100 ng/ml) for 0, 1, 2, 3, and 4
days, were transduced with 3,000 VP/cell of Ad-LacZ or Ad-
SOX17 for 1.5 h. Ad-SOX17-transduced cells were cultured with
Activin A (100 ng/ml) until day 5, then the cell viability was
evaluated with crystal violet staining. The horizontal axis
represents the day on which the cells were transduced with Ad-
SOX17. On the y axis, the level of non-transduced cells was taken
defined as 1.0. All data are represented as the means6SD (n=3).
(PDF)
Figure S8 Model of differentiation of human ESCs and
iPSCs into ExEn and DE cells by stage-specific SOX17
transduction. The ExEn and DE differentiation process is
divided into at least two stages. In the first stage, human ESCs
differentiate into either PrE cells by treatment with BMP4 (20 ng/
ml) or mesendoderm cells by treatment with Activin A (100 ng/
Directive ExEn or DE Differentiation by SOX17
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tiation of each precursor cell into ExEn and DE cells, respectively.
We have demonstrated that the efficient differentiation of these
two distinct endoderm lineages is accomplished by stage-specific
SOX17 transduction.
(PDF)
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